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Background: The previous study showed that the cardiac arrhythmias induced by myocardial ischemia and
reperfusion were attenuated by the pretreatment of acupuncture; however, the related mechanism is not understood.
The present study was therefore designed to determine whether intracellular Ca2+ ([Ca2+]i) and connexin 43 (Cx43) are
involved in the mediation of the anti-arrhythmic effect of electro-acupuncture (EA) pretreatment in the rats subjected
to simulative global ischemia and reperfusion (SGIR).
Methods: SGIR was made in the isolated heart by a low flow perfusion followed by a flow restoration. Four groups
of animals are involved in the present study, including normal control group, SGIR group, EA group and EA plus 18
beta-glycyrrhetinic acid (EAG) group. For EA pretreatment, bilateral Neiguan acupoints (PC6) of the rats were stimulated
for 30 min once a day in 3 consecutive days. Cx43 antagonist was given to the rats in EAG group 30 minutes before the
EA pretreatment. The resting [Ca2+]i concentration, calcium oscillation, the contents of total Cx43 and non-phosphrylated
Cx43 and arrhythmia score were compared among different groups.
Results: In EA group, the arrhythmic score, the resting [Ca2+]i concentration and the number of [Ca
2+]i oscillations were
all significantly less than those in SGIR group (all P < 0.05), and interestingly, after EA pretreatment, the contents of
nonphosphated Cx43 in the EA group were significantly lower than that in SGIR group respectively (P < 0.05). However,
when the rats were treated with Cx43 antagonist prior to the EA pretreatment, the protection effects induced by EA
pretreatment were reversed.
Conclusions: The results showed that EA pretreatment could produce anti-arrhythmic effect in the rats subjected
to SGIR. The anti-arrhythmic effect of EA pretreatment may be due at least partially to the inhibition of SGIR-induced
calcium overload and [Ca2+]i oscillations, reduction of non-phosphorylated Cx43 and the enhancement of the
corresponding phosphorylated Cx43 in the cardiac cells.
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The sudden cardiac death can be easily induced by the
severe ischemic arrhythmias including ventricular fib-
rillation occurred during the myocardial ischemia [1].
Acupuncture was reported to improve myocardial ische-
mia and attenuate arrhythmias [2-4]. In early 1980s, Guo
and colleagues reported that the extrasystole induced by
hypothalamic stimulation could be inhibited significantly
by the somatic nerve stimulation [5,6]. More recently,
the electro-acupuncture (EA) was shown to diminish
the susceptibility to ventricular tachycardia by reducing
cardiac metabolic demand [7]. A possible important role
of intracellular Ca2+ ([Ca2+]i) in the mediation of the anti-
arrhythmic effect of EA has been suggested by Longurst
[3]. Our previous study showed that the cardiac arrhyth-
mias induced by myocardial ischemia and reperfusion
(MIR) could be attenuated by the pretreatment of acu-
puncture via inhibiting the ischemia-elevated response
of [Ca2+]i [8]. However, detailed mechanisms underlying
the anti-arrhythmic effect of acupuncture have not been
elucidated yet.
The gap junction between the cardiac cells is composed
of two connexins from the neighboring cardiomyocytes’
membrane and plays an important role in the cell-to-
cell communication between cardiac cells. In ventricle
the major junction protein is connexin 43 (Cx43) which
ensures cardiac electric conduction and electric synchron-
icity. Alteration of Cx43 in quantity, phosphorylation and
distribution may cause cardiac electrically conductive
disorder and result in arrhythmias eventually. Cx43 is
known to be a functionally calcium-associated protein
[9]. The previous experimental study has demonstrated
that Cx43 remodeling may account for intercellular
calcium overload which is also associated with induc-
tion of ischemic arrhythmia [10]. Actually, intracellular
calcium oscillations, known to be related to the early
and delayed afterdepolarizations, are directly associated
with the occurrence of arrhythmias [11,12]. In addition,
the arrhythmia-related calcium oscillations are frequently
observed during MIR [13,14].
In order to determine whether Cx43 and [Ca
2+]i are
involved in the mediation of the anti-arrhythmic effect
produced by EA pretreatment, the arrhythmia score,
resting [Ca2+]i concentration, calcium oscillations, the
content of total Cx43 protein and the content of non-
phosphorylated Cx43 in cardiac myocytes isolated from
the heart subjected to the simulative global ischemia-
reperfusion (SGIR) were measured in the present study.
Methods
Animal grouping and electro-acupuncture pretreatment
The present study was approved by the Committee on
the Use of Live Animals in Research of the China Acad-
emy of Chinese Medical Sciences. Male Sprague–Dawleyrats weighing 200–225 g were randomly divided into
four groups, namely, normal control (NC) group,
simulative global ischemia-reperfusion (SGIR) group,
electro-acupuncture (EA) group and EA plus 18 beta-
glycyrrhetinic acid (EAG) group. Before the experiments,
the animals in EA and EAG groups were both pretreated
with EA applied at bilateral Neiguan acupoints (PC 6,
according to the textbook of experimental acupuncture,
Neiguan acupoint is located on forelimbs and was most
frequently and effectively used to treat cardiac malfunc-
tions including arrhythmias in clinical and experimental
researches) under anesthesia with urethane (1 g/kg) for
30 min once a day for three consecutive days. For
acupuncture manipulation, two needles, with 2–3 mm
apart from each other, were inserted through the skin
to a depth of about 2 mm at each Neiguan acupoint.
And then they were connected to positive and negative
poles of EA apparatus. The stimulatory intensity and
frequency of EA were 1–3 mA and 20 Hz respectively.
18 beta-glycyrrhetinic acid, an antagonist of Cx43, was
administered intraperitoneally in the rats of EAG group
at a dose of 160ug/kg 30 min before EA pretreatment.
The animals in NC and SGIR groups were treated
equally as those in EA and EAG groups except the
treatment of EA or 18 beta-glycyrrhetinic acid.Langendorff perfused isolated rat heart preparation
The Langendorff isolated perfused rat hearts were pre-
pared for the study of arrhythmias as described previously
[15]. In brief, male Sprague Dawley rats were sacrificed
by decapitation with a guillotine immediately after the
3rd-day EA treatment was completed and arrhythmias
recording were finished. Hearts were removed immedi-
ately and perfused retrogradely with a Krebs-Ringer
solution which was aerated with 95% O2 and 5% CO2,
pH 7.4, under a pressure of 55–70 mmHg and a constant
flow rate of 13 ml/min. The temperature of the heart was
maintained at 37°C. The first 10 min of perfusion allowed
the heart to stabilize and any heart exhibiting arrhythmias
during this period was discarded. The hearts in SGIR
group, EA group and EAG group were initially perfused at
a rate of 13 ml/min for 10 min, which was followed by a
reduced-flow perfusion at a rate of 0.5 ml/min for 40 min.
After reduced-flow perfusion, the perfusing flow was
restored to the control level for 10 min. In NC group the
hearts were perfused at a constant flow rate of 13 ml/min
without reduced-flow perfusion for 60 min. Although
there were occasional arrhythmias during the low flow
period, arrhythmias appeared more frequently when the
flow was restored as observed in previous study and our
preliminary observation [16]. In the present study we de-
termined the arrhythmias within 10 min immediately after
the restoration of perfusion, namely, the reperfusion.
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ECG was continuously monitored with standard lead II
throughout the experiment with a positive electrode
hooked to the apex of the heart and a negative electrode
at the aorta. To make comparison the arrhythmia scoring
system modified from previous studies was adopted [17].
The principles of the scoring system employed were as
follows. (1) Ventricular arrhythmias are more severe than
atrial arrhythmias; (2) the severity of ventricular arrhyth-
mias are ventricular fibrillation (VF), ventricular tachy-
cardia (VT), frequent premature ventricular contraction
(PVC) and occasional PVC in descending order; (3) the
longer the duration of arrhythmias or the more frequent
the incidence of arrhythmias, the greater the severity of
arrhythmias. In the present study, the score of a heart was
that of the most severe type of arrhythmia exhibited by
the heart. The details of the scoring system are shown in
the Table 1.
Measurement of cytosolic free [Ca2+]i
Ventricular myocytes of Sprague Dawley rats were
isolated using a collagenase perfusion method [18]. The
cells were loaded with fura-2/AM as a Ca2+ indicator,
and [Ca2+]i transient was determined by a spectrofluoro-
metric method as described previously [19]. Briefly, the
ventricular myocytes loaded with fura-2/AM were trans-
ferred to the stage of an inverted microscope (Nikon) in a
superfusion chamber at room temperature. The ventricu-
lar myocytes were adapted for 20 min in the perfusion
chamber before Ca2+ measurement. The fluctuation of
[Ca2+]i concentration was then recorded for 10 minutes in
each selective resting single ventricular myocyte and the
recorded values were averaged. A spike-like spontaneous
increase in [Ca2+]i with amplitude over two times of the
standard deviation of the quiescent [Ca2+]i variations was
determined as an oscillation [20].
Measurement of content of cardiac Cx43
Ventricular tissue of the heart was isolated in the end of
perfusion experiments and immediately frozen. On the
day of preparation of ventricular sarcolemma, the stored
ventricle was homogenized in hypotonic membrane buffer
containing 1 mM 1, 10-phenanthroline, 1 mM iodoaceta-
mide, 1 mM pepstatin A, 0.4 mM phenylmethylsulfonyl
fluoride (PMSF) with ultrasound homogenizer (Sonics &Table 1 Arrhythmia scoring system
Arrhythmia score Type of arrhythmia
0 No arrhythmia
1 Atrial arrhythmias or occasional PVC
2 Frequent PVC
3 VT (1–2 episodes)
4 VT (>3 episodes) or VF (1–2 episodes)Material Inc, Jencons Ltd. Germany) . A modified Western
blotting technique was used to determine the content of
cardiac Cx43 [21].
Drugs and chemicals
Type I collagenase, Joklik modified Eagle medium,
HEPES, fura-2/AM, 18 and beta-glycyrrhetinic acid were
purchased from Sigma Chemical Co; anti-glyceraldehyde-
3-phosphate dehydrogenase antibody, polyclonal and
monoclonal anti-Cx43 antibodies as well as the corre-
sponding horseradish peroxidase-conjugated secondary
antibodies were obtained from Santa Cruz Biotech.
(Santa Cruz, CA). All the chemicals were dissolved in
distilled water except fura-2/AM, which was dissolved
in diethyl sulphoxide (DMSO).
Statistical analysis
All the data in the present study are presented as Mean ±
SE. A one-way ANOVA was used for multiple group com-
parisons and Dunnett’s T-test for two group comparison.
P value less than 0.05 was considered as statistical
significance.
Results
EA pretreatment and anti-arrhythmia in rats subjected to
SGIR
Figure 1A shows the ECG traces recorded in isolated
hearts from different groups. Arrhythmias were frequently
observed in SGIR and EAG groups. The arrhythmic score
(Figure 1B) was zero in NC group, suggesting no
arrhythmia was observed. However, atrial and ventricular
arrhythmias occurred in SGIR group with an arrhythmia
score of 3.75 ± 0.25 (P < 0.05 vs NC group). Interestingly,
the arrhythmia score was 0.75 ± 0.25 in EA group, indi-
cating that the incidence of arrhythmias is significantly de-
creased (P < 0.05) with EA pretreatment. When the animals
was pretreated intraperitoneally with the Cx43 inhibitor 18
beta-glycyrrhetinic acid, the arrhythmic score was 2.89 ±
0.18 with EA treatment. This result demonstrates Cx43
mediates the attenuation of arrhythmias induced by EA.
EA pretreatment and [Ca2+]i in resting single ventricular
myocyte isolated from the perfused heart subjected to SGIR
Figure 2A displays the representative resting [Ca2+]i
recordings in ventricular myocytes. Spontaneous [Ca2+]i
oscillations were observed in the cells of SGIR group, but
not in the cells of normal control group. The frequency of
spontaneous [Ca2+]i was reduced in the cells of EA group.
Figure 2B illustrates the mean values of resting [Ca2+]i
and [Ca2+]i oscillations in single ventricular myocyte
from different groups. The resting [Ca2+]i was 73.67 ±
1.08 nmol/L in NC group, 110.42 ± 1.49 nmol/L in SGIR
group, 85.42 ± 1.56 nmol /L in EA group, and110.42 ±
1.64 nmol/L in EAG group. The mean value of resting
Figure 1 Effect of EA pretreatment on ischemic arrythmias in the
isolated heart subjected to SGIR. Panel A: Representative traces of
ECG showing the cardiac arrhythmias in the rats of different groups.
Panel B: Statistical results of arrhythmic scores evaluating the cardiac
arrhythmias recorded 10 minutes after reperfusion in the different
groups. NC = normal control group; SGIR = simulative global ischemia
& reperfusion group; EA = electro-acupuncture group; EAG = electro-
acupuncture plus 18-beta-glycyrrhetinic acid group. *P < 0.05 vs.
control group; #P < 0.05 as compared with SGIR group; +P < 0.05 in
comparison with EA group. (n = 10).
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NC group), and the increased resting [Ca2+]i was remark-
ably countered by repetitive EA pretreatment (P < 0.01 vs
SGIR group). Interestingly, the response of resting [Ca2+]i
to EA treatment was attenuated by the Cx43 inhibitor
18-beta-glycyrrhetinic acid (P < 0.01 vs EA group).EA pretreatment and SGIR-induced [Ca2+]i oscillations in
resting single ventricular myocyte
Figure 2C shows that no [Ca2+]i oscillations in resting
single ventricular myocyte from hearts of different
groups. The [Ca2+]i oscillation number in SGIR group
was 43.83 ± 2.68, significantly higher than zero in NC
group (P < 0.01); The increased [Ca2+]i oscillation num-
ber was significantly reduced to 8.33 ± 1.58 in EA group
(P < 0.01 vs SGIR group). The EA-reduced resting cal-
cium oscillation number was reversed to 34.00 ± 2.11 by
the Cx43 inhibitor 18-beta-glycyrrhetinic acid (P <0.01 vs
EA group).EA pretreatment and Cx43 protein levels in ventricular
myocytes
Figure 3 displays the Western blot results for total Cx43
protein expression in the ventricular tissue from different
groups. The total Cx43 (kD 46 and kD 41) was reduced by
the different treatments of SGIR, EA and EAG. The aver-
age values of the optical density for Cx43 protein (relative
to GAPDH) were 15.81 ± 0.79, 16.14 ± 0.44 and 15.48 ±
0.96 in SGIR, EA and EAG groups respectively, signifi-
cantly lower than that (19.22 ± 0.69) in NC group. How-
ever, no significant difference was observed among SGIR,
EA and EAG groups (P > 0.05).
EA pretreatment and nonphosphorylated Cx43 in
ventricular myocytes isolated from the perfused hearts
subjected to SGIR
Figure 4 shows the optical protein density of non-
phosphated Cx43 in different groups. The relative mean
values of nonphosphated Cx43 level (Figure 4B) was in-
creased to 1.99 ± 0.10 in SGIR group from 0.83 ± 0.11 of
NC group (P < 0.05). The increased nonphosphated Cx43
level was significantly reduced to 0.90 ± 0.14 by EA
pretreatment (P < 0.05 vs SGIR group); however, the EA
effect was antagonized by the Cx43 inhibitor 18-beta-
glycyrrhetinic acid (2.05 ± 0.16, P < 0.05 vs EA group).
Discussion
Actually, acupuncture has been using by Chinese people
for health care and prevention of various diseases since
ancient time. Currently, acupuncture in China is being
used not only to routinely treat patients with various
diseases, but also to provide people with health care
services like keeping fit, preventing aging, treating sub-
health and so on.
In the past several decades scientists and medical doc-
tors have tried their best to seek the preventive measures
for the prevention of the acute attack of myocardial
ischemia or coronary heart disease (CHD). It was found
that ischemia preconditioning can effectively attenuate
the cardiac injury induced by the subsequent severe
myocardial ischemia. Unfortunately, this kind of protect-
ive or preventive measure is not clinically practicable.
Acupuncture has been shown to attenuate the cardiac
injury induced by MIR [22, 23]. However, patients with
CHD rarely go to an acupuncturist because CHD at an
acute stage is usually too urgent to be treated only by
acupuncture. Therefore, seeking a proper way for acu-
puncture, an economic and simple therapy, to treat or
prevent CHD is clinically beneficial. Pre-treatment with
acupuncture, i.e., treating the people susceptible to CHD
before they are acutely attacked, may be practicable in
clinic for acupuncture to treat and prevent the disease.
The first observation in the present study is that the
arrhythmic score in EA group was significantly less than
Figure 2 Effect of EA pretreatment on [Ca2+]i concentration and [Ca
2+]i oscillations in resting single ventricular myocyte. Panel A:
Representative traces of Ca2+ transient in resting single ventricular myocyte of different groups. Panel B: Statistical results of resting [Ca2+]i
concentration in single ventricular myocyte of different groups. Panel C: Statistical graph showing the oscillations in resting single ventricular
myocyte of different groups. NC = normal control group; SGIR = simulative global ischemia & reperfusion group; EA = electro-acupuncture
group; EAG = electro-acupuncture plus 18-beta-glycyrrhetinic acid group. **P < 0.01 vs. control group; ##P < 0.01 as compared with SGIR group;
++P < 0.01 in comparison with EA group. (n = 20).
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effect is achieved by EA pretreatment. The results are
similar to that of our previous study showing that the
repetitive pretreatment with EA at PC6 acupoints pro-
duced a greater cardioprotective effect than the same
stimulation at non-acupoints did [8].
As we know, in many clinical studies of acupuncture
people have tried their best to design clinical trials
carefully to eliminate the mental influence on the
therapeutic effect of acupuncture. Therefore, although
anesthesia has its shortage in the study of acupuncture
as it may influence somewhat the effect of acupuncture,
anesthesia is also of advantage in this kind of study due
to that it can exclude the psychological disturbance. In
the past decades many experimental studies conducted
on the anesthetized animals have been published in top
journals, showing a popular acceptance of the acupunc-
ture studies carried out on the anesthetized animals. In
addition, in the present study the rats in all groups in-
cluding experimental and control ones were anesthetized
equally and we can easily find out the significant differ-
ences of the recorded data between the EA group and
SGIR group.It is well recognized that during MIR [Ca2+]i is increased,
even overloaded due to the disorder of calcium homeostasis
modulators. The [Ca2+]i enhancement can lead to [Ca
2+]i
oscillations resulted from the increased release of Ca2+
from sarcoplasmic reticulum. The [Ca2+]i and its oscillation
enhancement during and after repolarization phase are
known to be arrhythmia-related substrates [24]. When
heart is undergone ischemia and reperfusion, the sym-
pathetic nervous system is over-excited [25]. which
increases the release of catecholamine and leads to an
over-stimulation of cardiac β1-adrenoceptor (β1-AR). The
sensitivity and activity of β-adrenoceptors (β-ARs) are also
facilitated during MIR [26]. While β1-AR stimulation is
known to cause the increase in [Ca2+]i, even [Ca
2+]i over-
load [27], so as to bring about arrhythmias [28]. Therefore,
both overstimulation of β-ARs and enhancement of [Ca2+]
i are considered as the arrhythmogenic substrates. Ische-
mia preconditioning, i.e. several times of short ischemia, is
well known to protect the myocardium from the injury
induced by following severe MIR [29]. Repetitive pretreat-
ment of the cardiac myocytes with β-ARs agonist [30],
high concentration of Ca2+ and the opener of L-Ca2+
channel can separately produce the same cardioprotective
Figure 3 Effect of EA pretreatment on Cx43 protein content in
heart of rats subjected to SGIR. Panel A: Representative traces of
electrophoresis of myocardial Cx43 protein at 41 and 46 kilo-Dalton
after probed with polyclonal anti-Cx43 antibody in different groups.
Panel B: Group results showing the changes of relative density of
myocardial Cx43 protein in different groups. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was taken as the internal
control. (n = 20).
Figure 4 Effect of EA pretreatment on Cx43 phosphorylation in
perfused hearts subjected to SGIR. Panel A: Representative traces
of electrophoresis of myocardial Cx43 protein at 41 kilo-dalton after
probed with monoclonal anti-Cx43 antibody in different groups. Panel
B: Group results showing the changes of relative density of myocardial
nonphosphorylated Cx43 protein in different groups. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was taken as the internal control.
*P < 0.05 as compared with control group; #P < 0.05 in comparison
with SGIR group; +P < 0.05 in comparison with EA group (n = 20).
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esting that the activity of the sympathetic nervous system
was reported to be affected by somatic stimulation [33]. It
was also shown that EA stimulation significantly enhanced
sympathetic activity [34]. Thus, the repetitive EA pretreat-
ment may also achieve the cardioprotective effects via
stimulating sympathetic nervous system and β1-AR. Our
previous study showed that pretreatment with EA protects
the heart from ischemic injury via inducing the functional
attenuation of cardiac β1-AR [35]. Thus, we hypothesized
an involvement of cardiac [Ca2+]i in the mediation of the
anti-arrhythmic effect of EA pretreatment. Our data
showed that SGIR-induced increase of arrhythmic score
was significantly attenuated with repetitive EA pretreat-
ment and SGIR-induced increase in both quiescent [Ca2+]i
concentration and the number of [Ca2+]i oscillations was
also reduced by EA pretreatment. The results indicate that
EA pretreatment may exert an anti-arrhythmic effect via
reducing the augmented [Ca2+]i concentration and oscilla-
tions by SGIR.
In brief, as shown in the hypothetical diagram of
Figure 5, the possible mechanisms underlying the inhib-
ition of calcium oscillations by EA pretreatment are as
follows. Repetitive EA pretreatment may increase repeti-
tively the activity of sympathetic nervous system (SNS)
and the release of norepinephrine from the endings ofSNS. The repetitively-enhanced norepinephrine then sti-
mulates repetitively β1-AR and its down-stream signaling
components, which may induce an adaptation or toler-
ance of the myocytes’ responsiveness to MIR which is
known to increase [Ca2+]i and induce [Ca
2+]i oscillations.
Thus, the repetitive EA pretreatment-induced tolerance or
adaptation to the [Ca2+]i -enhancing MIR may finally re-
duce the [Ca2+]i concentration and its oscillations as well.
Gap junctions, assembled with connexins, form cell-to-
cell pathways for propagation of current flow, play an
important role in the synchronous contraction of cardiac
myocytes [36]. Cx43 is the predominant connexin expressed
abundantly in ventricular and atrial myocytes. There are
two different status of Cx43, namely, phosphorylated
and non-phosphorylated ones. It is known so far that
the phosphorylated Cx43 is a functionally active one,
while the nonphosphorylated or dephosphorylated one
is of no functional activity. Almost all the Cx43 are
phosphorylated under normal condition, while during
ischemia, Cx43 was progressively dephosphorylated without
any changes in total content of Cx43 [37]. The alterations of
Cx43 expression and phosphorylation status may induce
serious arrhythmogenic substrate via attenuating the cell-
to-cell coupling [38]. Furthermore, Cx43 was recently
shown to play a role in mediating the cardioprotective
Figure 5 Hypothetical diagram showing the possible targeted points mediating the anti-arrhythmic effect of EA pretreatment. During
MIR both sympathetic nervous system (SNS) and β-adrenoceptors (β-AR) were over excited, which leads to intracellular calcium ([Ca2+]i) overload
and [Ca2+]i oscillations; in addition, MIR also causes the reduction of total and phosphorylated Cx43, which subsequently attenuates the intercellular electric
conductance and the cardiac electric synchronicity. Both the reduction of cardiac electric synchronicity and enhancement of [Ca2+]i oscillations which
is known to be related to early and delayed afterdepolarization can result in cardiac arrhythmias. On the one hand, repetitive electro-acupuncture (EA)
pretreatment may finally produce the anti-arrhythmic effect via inducing an adaptation of β-AR to the stimulation of catecholamine released from the
terminals of SNS, and bringing about the inhibition of both [Ca2+]i overload and [Ca
2+]i oscillations; on the other hand, EA pretreatment may also
inhibit the MIR-induced reduction of total or phosphorylated Cx43, which consequently enhances the cardiac electric synchronicity and then diminishes
the occurrence of arrhythmias.
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sible involvement of Cx43 in the mediation of the anti-
arrhythmic effect produced by repetitive EA pretreatment
which mimics ischemia preconditioning. In the present
study, although there was no significant difference in total
content of Cx43 among NC, SGIR, EA and EAG groups,
the level of nonphosphated Cx43 in the SGIR group was
significantly higher than that in NC group (P <0.05). The
increase in the nonphosphated Cx43 protein level was con-
comitant with the augmentation of [Ca2+]i concentration,
[Ca2+]i oscillations and arrhythmia score. However, the
nonphosphorylated Cx43 was significantly lower in EA
group as compared with SGIR group, implying the im-
provement of the SGIR-impaired gap junction following
the repetitive EA pretreatment. More interestingly, when
the rats were treated with Cx43 antagonist 18-beta-glycyrrhetinic acid prior to the EA pretreatment, the EA
pretreatment-induced attenuation of nonphosphorylated
Cx43 was reversed, which supports the notion that Cx43
may be involved in the mediation of the anti-arrhythmic
effect of EA pretreatment.
Conclusions
In summary, EA could prevent cardiac arrhythmias in-
duced by SGIR, this effect may be due, at least partly, to
the inhibition on the Ca2+ overload, oscillations and the
reduction of non-phosphorylated Cx43.
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